These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1217 related articles for article (PubMed ID: 12933696)

  • 1. Dual role of SRC homology domain 2-containing inositol phosphatase 2 in the regulation of platelet-derived growth factor and insulin-like growth factor I signaling in rat vascular smooth muscle cells.
    Sasaoka T; Kikuchi K; Wada T; Sato A; Hori H; Murakami S; Fukui K; Ishihara H; Aota R; Kimura I; Kobayashi M
    Endocrinology; 2003 Sep; 144(9):4204-14. PubMed ID: 12933696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
    Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
    Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
    Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
    Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
    Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
    Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Src homology 2-containing inositol 5'-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids.
    Murakami S; Sasaoka T; Wada T; Fukui K; Nagira K; Ishihara H; Usui I; Kobayashi M
    Endocrinology; 2004 Jul; 145(7):3215-23. PubMed ID: 15044364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
    Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
    Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of PDGF-stimulated SHIP2 tyrosine phosphorylation and association with Shc in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Ibrahim S; Sorisky A
    J Cell Physiol; 2007 Jun; 211(3):598-607. PubMed ID: 17219406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis.
    Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling.
    Ishihara H; Sasaoka T; Hori H; Wada T; Hirai H; Haruta T; Langlois WJ; Kobayashi M
    Biochem Biophys Res Commun; 1999 Jun; 260(1):265-72. PubMed ID: 10381377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.
    Sasaoka T; Wada T; Fukui K; Murakami S; Ishihara H; Suzuki R; Tobe K; Kadowaki T; Kobayashi M
    J Biol Chem; 2004 Apr; 279(15):14835-43. PubMed ID: 14744864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucosamine enhances platelet-derived growth factor-induced DNA synthesis via phosphatidylinositol 3-kinase pathway in rat aortic smooth muscle cells.
    Sato A; Sasaoka T; Yamazaki K; Nakamura N; Temaru R; Ishiki M; Takata M; Kishida M; Wada T; Ishihara H; Usui I; Urakaze M; Kobayashi M
    Atherosclerosis; 2001 Aug; 157(2):341-52. PubMed ID: 11472733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
    Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C
    Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytically inactive SHIP2 inhibits proliferation by attenuating PDGF signaling in 3T3-L1 preadipocytes.
    Artemenko Y; Gagnon A; Sorisky A
    J Cell Physiol; 2009 Jan; 218(1):228-36. PubMed ID: 18814181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTEN, but not SHIP and SHIP2, suppresses the PI3K/Akt pathway and induces growth inhibition and apoptosis of myeloma cells.
    Choi Y; Zhang J; Murga C; Yu H; Koller E; Monia BP; Gutkind JS; Li W
    Oncogene; 2002 Aug; 21(34):5289-300. PubMed ID: 12149650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
    J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of SRC homology 2-containing inositol 5'-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling.
    Kagawa S; Sasaoka T; Yaguchi S; Ishihara H; Tsuneki H; Murakami S; Fukui K; Wada T; Kobayashi S; Kimura I; Kobayashi M
    J Clin Endocrinol Metab; 2005 May; 90(5):2911-9. PubMed ID: 15687335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Src homology 2 domain containing inositol 5-phosphatase SHIP2 is recruited to the epidermal growth factor (EGF) receptor and dephosphorylates phosphatidylinositol 3,4,5-trisphosphate in EGF-stimulated COS-7 cells.
    Pesesse X; Dewaste V; De Smedt F; Laffargue M; Giuriato S; Moreau C; Payrastre B; Erneux C
    J Biol Chem; 2001 Jul; 276(30):28348-55. PubMed ID: 11349134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative signaling pathways of insulin-like growth factor-1 and brain-derived neurotrophic factor in hippocampal neurons and the role of the PI3 kinase pathway in cell survival.
    Zheng WH; Quirion R
    J Neurochem; 2004 May; 89(4):844-52. PubMed ID: 15140184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
    Pukac L; Huangpu J; Karnovsky MJ
    Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 61.